Michael Seely is the founder of Ascus Biosciences. Ascus Biosciences has raised $46M in total funding. Latest round: Series B. Based in Vista, CA.
Michael Seely is the chief executive officer of Ascus Biosciences, a deep science animal health and nutrition company. He led the company in securing $46 million in Series B funding, which will be used to expand customer sales and servicing teams, advance the product pipeline, and refine their technology platform.
Full founder directory · Investor directory · Company funding database · Fundraising library